HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Resection of adrenal metastases from non-small cell lung cancer: a multicenter study.

AbstractBACKGROUND:
In recent case reports and limited series, adrenalectomy was recommended for an isolated adrenal metastasis from non-small cell lung cancer (NSCLC).
METHODS:
We retrospectively studied patients with a solitary adrenal metastasis from NSCLC who had undergone potentially curative resection in eight centers.
RESULTS:
Forty-three patients were included. Their adrenal gland metastasis was discovered synchronously with NSCLC in 32 patients, and metachronously in 11. It was homolateral to the NSCLC in 31 patients and contralateral in 12 (p < 0.01). Median survival was 11 months, and 3 patients survived more than 5 years. There was no difference between the synchronous and metachronous groups regarding recurrence rate or survival. Survival was not affected by the homolateral location of the metastasis, the histology of the NSCLC, TNM stage, any adjuvant and neoadjuvant treatment, or, in the metachronous group, a disease-free interval exceeding 6 months.
CONCLUSIONS:
We confirm the possibility of long-term survival after resection of isolated adrenal metastasis from NSCLC, but no clinical or pathologic criteria were detected to identify patients amenable to potential cure.
AuthorsH Porte, J Siat, B Guibert, F Lepimpec-Barthes, R Jancovici, A Bernard, A Foucart, A Wurtz
JournalThe Annals of thoracic surgery (Ann Thorac Surg) Vol. 71 Issue 3 Pg. 981-5 (Mar 2001) ISSN: 0003-4975 [Print] Netherlands
PMID11269485 (Publication Type: Journal Article, Multicenter Study)
Topics
  • Adrenal Gland Neoplasms (mortality, secondary, surgery)
  • Adrenalectomy
  • Adult
  • Aged
  • Carcinoma, Non-Small-Cell Lung (mortality, secondary, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms (pathology)
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (epidemiology)
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: